FDA OKs Late-Stage Breast Cancer Drug

Friday, 22 Feb 2013 12:27 PM

 

Share:
A    A   |
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink
U.S. health regulators said on Friday they have approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who have failed other therapies.
 
The U.S. Food and Drug Administration said it approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.
 
The drug's label will carry a boxed warning, the most serious possible, of the drug's potential to cause liver and heart toxicity and death. The drug can also cause life-threatening birth defects.
 
In clinical trials, patients who took the drug, known during its development process as T-DM1, survived an average of 30.9 months, compared with 25.1 months in the control group.

Special: This Small Group of Doctors are Quietly Curing Cancer

© 2014 Thomson/Reuters. All rights reserved.

Share:
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Glimmer of Hope Amid US Diabetes Epidemic

Wednesday, 16 Apr 2014 17:43 PM

In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the d . . .

Valerie Harper 'Cautiously Optimistic' in Cancer Battle

Wednesday, 16 Apr 2014 17:34 PM

TV star Valerie Harper says she is doing well in her fight against a rare form of brain cancer and that her medical team . . .

Leeches Help Save Teen's Ear After Pit Bull Attack

Wednesday, 16 Apr 2014 17:06 PM

A savage pit bull attack results in the total dismembering of a teenage girl's ear. And though the ear remains fully int . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved